Job Description

• Salary in the range of \xc2\xa321,220 - \xc2\xa329,000 per annum (dependent upon experience)
• Job Ref: MI/23/24
• Duration: fixed term until 31.03.2025 (in the first instance)

About the role:

The Cancer Biomarker Centre (CBC) aims to enhance clinical trials of new anticancer drugs through translational research. Histological and molecular profiling of patient samples is essential to understand clinical disease heterogeneity, to profile drug targets and to identify biomarkers for precision medicine approaches in oncology.

We are currently seeking to appoint a Scientific Officer with a keen interest in the development of novel therapies to improve cancer patient outcomes. With support and discussion from Team Leader, the post holder will conduct translational research focusing on tissue-based biomarkers within a collaborative partnership between the Cancer Biomarker Centre and Boehringer Ingelheim. This exciting opportunity is available immediately. You will become part of a wider team testing efficacies of novel therapeutics with parallel development of tissue biomarkers to optimise their application in the clinic.

About you:

You should have a BSc (or equivalent) in Biological Sciences or related subject (or have equivalent relevant experience). You will have relevant experience in working in a Life Science Laboratory. Although in-house training in specialist techniques will be provided where required to acquire the necessary skill set, you will have experience in immunohistochemical (IHC) methods, including chromogenic and immunofluorescent analysis methods, in biomarker analysis of clinical tissue and biomarker assay development and validation.

Key qualities include independent thinking, ability to work in a team and good communication skills, all of which are needed to efficiently work in a multidisciplinary team.

Why choose the CRUK Cancer Biomarker Centre?

We are an internationally leading biomarker centre aligned to the world leading Cancer Research UK Manchester Institute ( ), an Institute of The University of Manchester ( ), The Biomarker Centre and Manchester Institute are core funded by Cancer Research UK ( ), the largest independent cancer research organisation in the world.

The Cancer Biomarker Centre is located in the New Paterson Building, a \xc2\xa3150 million flagship purpose-built biomedical research facility directly attached to The Christie NHS Foundation Trust in South Manchester. Situated on the third floor, the Cancer Biomarker Centre offers world-class research facilities with bespoke, purpose-built suite of laboratories in close proximity to discovery science collaborators and the Christie Hospital\'s clinical trialists.

Our Centre\'s aim is to discover, develop, validate and qualify biomarkers that support optimised treatment of patients with cancer. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to translational research and biomarker driven clinical trials.

As an equal opportunities employer we welcome applicants from all sections of the community regardless of age, sex, gender (or gender identity), ethnicity, disability, sexual orientation and transgender status. All appointments are made on merit.

Blended working arrangements may be considered.

Our University is positive about flexible working - you can find out more

To apply please go to

For any informal enquiries about this post, please contact Kathryn Simpson: or Derrick Morgan:



General enquiries:
Email:

Technical support:
Email:

This vacancy will close for applications at midnight on the closing date.

Please see the link below for the Further Particulars document which contains the person specification criteria.

University of Manchester